|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-9
|
|
pubmed:abstractText |
Very few tracers are currently available for the detection and staging of prostate cancer with positron emission tomography and single-photon emission computed tomography. This study evaluates the potential of 8-[123I]iodo-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid [ITIC(OH)] as an imaging agent for prostate cancer in experimental models of human prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0969-8051
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
99-107
|
|
pubmed:meshHeading |
pubmed-meshheading:17210466-Animals,
pubmed-meshheading:17210466-Cell Line, Tumor,
pubmed-meshheading:17210466-Disease Models, Animal,
pubmed-meshheading:17210466-Drug Evaluation, Preclinical,
pubmed-meshheading:17210466-Humans,
pubmed-meshheading:17210466-Male,
pubmed-meshheading:17210466-Metabolic Clearance Rate,
pubmed-meshheading:17210466-Mice,
pubmed-meshheading:17210466-Mice, Nude,
pubmed-meshheading:17210466-Organ Specificity,
pubmed-meshheading:17210466-Prostatic Neoplasms,
pubmed-meshheading:17210466-Radiopharmaceuticals,
pubmed-meshheading:17210466-Tetrahydroisoquinolines,
pubmed-meshheading:17210466-Tissue Distribution
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Validation of 8-[123I]iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Saarland University Medical Center, D-66421 Homburg, Germany. rassam@uniklinikum-saarland.de
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies,
Validation Studies
|
